| Year | Title | Author(s) |
|---|
| 2013 |
Modeling distinct osteosarcoma subtypes in vivo using Cre:lox and lineage-restricted transgenic shRNA
Bone |
Mutsaers, AJ Ng, AJM Baker, EK Russell, MR Chalk, AM Wall, M Liddicoat, BJJ Ho, PWM Slavin, JL Goradia, A Martin, TJ Purton, LE Dickins, RA Walkley, CR |
| 2013 |
Essential Developmental, Genomic Stability, and Tumour Suppressor Functions of the Mouse Orthologue of hSSB1/NABP2
Plos Genetics |
Shi, W Bain, AL Schwer, B Al-Ejeh, F Smith, C Wong, L Chai, H Miranda, MS Ho, U Kawaguchi, M Miura, Y Finnie, JW Wall, M Heierhorst, J Wicking, C Spring, KJ Alt, FW Khanna, KK |
| 2014 |
The SKI proto-oncogene enhances the in vivo repopulation of hematopoietic stem cells and causes myeloproliferative disease
Haematologica |
Singbrant, S Wall, M Moody, J Karlsson, G Chalk, AM Liddicoat, B Russell, MR Walkley, CR Karlsson, S |
| 2014 |
The Rothmund-Thomson syndrome helicase RECQL4 is essential for hematopoiesis
Journal Of Clinical Investigation |
Smeets, MF DeLuca, E Wall, M Quach, JM Chalk, AM Deans, AJ Heierhorst, J Purton, LE Izon, DJ Walkley, CR |
| 2015 |
Src family kinases and their role in hematological malignancies
Leukemia & Lymphoma |
Ku, M Wall, M MacKinnon, RN Walkley, CR Purton, LE Tam, C Izon, D Campbell, L Cheng, HC Nandurkar, H |
| 2016 |
Adenosine-to-inosine RNA editing by ADAR1 is essential for normal murine erythropoiesis
Exp Hematol |
Seeburg, PH Ramaswami, G Purton, LE Li, JB Piskol, R Wall, M Lu, J Hartner, JC Sankaran, VG Orkin, SH Liddicoat, BJ Kingsley, PD Palis, J Chalk, AM Walkley, CR |
| 2016 |
The Transcription Factor ASCIZ and Its Target DYNLL1 Are Essential for the Development and Expansion of MYC-Driven B Cell Lymphoma
Cell Reports |
Wong, DM Li, LL Jurado, S King, A Bamford, R Wall, M Walia, MK Kelly, GL Walkley, CR Tarlinton, DM Strasser, A Heierhorst, J |
| 2017 |
Clinicopathological features and outcomes of progression of CLL on the BCL2 inhibitor venetoclax
Blood |
Anderson, MA Tam, C Lew, TE Juneja, S Juneja, M Westerman, D Wall, M Lade, S Gorelik, A Huang, DCS Seymour, JF Roberts, AW |
| 2018 |
Detection of clinically relevant early genomic lesions in B-cell malignancies from circulating tumour DNA using a single hybridisation-based next generation sequencing assay
Br. J. Haematol. |
Blombery, PA Ryland, GL Markham, J Guinto, J Wall, M McBean, M Jones, K Thompson, ER Cameron, DL Papenfuss, AT Prince, MH Dickinson, M Westerman, DA |
| 2018 |
Srsf2(P95H) initiates myeloid bias and myelodysplastic/myeloproliferative syndrome from hemopoietic stem cells
Blood |
Smeets, MF Tan, SY Xu, JJ Anande, G Unnikrishnan, A Chalk, AM Taylor, SR Pimanda, JE Wall, M Purton, LE Walkley, CR |
| 2019 |
What does good FISHing look like in MDS?
Leukemia & Lymphoma |
Wall, M Blombery, P |
| 2019 |
Hemopoietic Cell Kinase amplification with Protein Tyrosine Phosphatase Receptor T depletion leads to polycythemia, aberrant marrow erythoid maturation, and splenomegaly
Scientific Reports |
Ku, M MacKinnon, RN Wall, M Narayan, N Walkley, C Cheng, HC Campbell, LJ Purton, LE Nandurkar, H |
| 2019 |
Modeling human RNA spliceosome mutations in the mouse: not all mice were created equal
Exp. Hematol. |
Xu, JJ Srneets, MF Tan, SY Wall, M Purton, LE Walkley, CR |
| 2019 |
Azacitidine with or without lenalidomide in higher risk myelodysplastic syndrome & low blast acute myeloid leukemia
Haematologica |
Kenealy, M Hertzberg, M Benson, W Taylor, K Cunningham, I Stevenson, W Hiwase, D Eek, R Zantomio, D Jong, S Wall, M Blombery, P Gerber, T Debrincat, M Zannino, D Seymour, JF |
| 2019 |
Dynamic molecular monitoring reveals that SWI-SNF mutations mediate resistance to ibrutinib plus venetoclax in mantle cell lymphoma
Nat. Med. |
Agarwal, R Chan, YC Tam, CS Hunter, T Vassiliadis, D Teh, CE Thijssen, R Yeh, P Wong, SQ Ftouni, S Lam, EYN Anderson, MA Pott, C Gilan, O Bell, CC Knezevic, K Blombery, P Rayeroux, K Zordan, A Li, J Huang, DCS Wall, M Seymour, JF Gray, DHD Roberts, AW Dawson, MA Dawson, SJ |
| 2020 |
Failure of tofacitinib of achieve an objective response in a DDX3X-MLLT10 T-lymphoblastic leukemia with activating JAK3 mutations
Cold Spring Harbor Molecular Case Studies |
Wong, J Wall, M Corboy, GP Taubenheim, N Gregory, GP Opat, S Shortt, J |